Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform

Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and moni...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahoney, Martin C., Ashare, Rebecca, Schlienz, Nicolas, Duerr, CeCe, Hawk, Larry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403863/
https://www.ncbi.nlm.nih.gov/pubmed/32811627
http://dx.doi.org/10.1016/j.jsat.2020.108100
_version_ 1783567025166090240
author Mahoney, Martin C.
Ashare, Rebecca
Schlienz, Nicolas
Duerr, CeCe
Hawk, Larry W.
author_facet Mahoney, Martin C.
Ashare, Rebecca
Schlienz, Nicolas
Duerr, CeCe
Hawk, Larry W.
author_sort Mahoney, Martin C.
collection PubMed
description Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes.
format Online
Article
Text
id pubmed-7403863
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-74038632020-08-05 Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform Mahoney, Martin C. Ashare, Rebecca Schlienz, Nicolas Duerr, CeCe Hawk, Larry W. J Subst Abuse Treat Article Clinical trials represent an essential component of improving treatment for substance use disorders (SUD). The SARS coronavirus-2 pandemic disrupted our ongoing clinical trial of smoking cessation and forced us to rapidly implement changes to assure participants access to ongoing counseling and monitoring via telephone calls and/or video chat sessions. Our experiences suggest that this pandemic will lead to changes for both future clinical trial participants and project staff. While challenges remain, it will be important to assessing the impact of these changes with regard to participant experiences and treatment outcomes. Elsevier Inc. 2020-10 2020-08-05 /pmc/articles/PMC7403863/ /pubmed/32811627 http://dx.doi.org/10.1016/j.jsat.2020.108100 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mahoney, Martin C.
Ashare, Rebecca
Schlienz, Nicolas
Duerr, CeCe
Hawk, Larry W.
Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
title Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
title_full Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
title_fullStr Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
title_full_unstemmed Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
title_short Making lemonade from SARS coronavirus-2 lemons: Transitioning a smoking cessation trial to a virtual platform
title_sort making lemonade from sars coronavirus-2 lemons: transitioning a smoking cessation trial to a virtual platform
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403863/
https://www.ncbi.nlm.nih.gov/pubmed/32811627
http://dx.doi.org/10.1016/j.jsat.2020.108100
work_keys_str_mv AT mahoneymartinc makinglemonadefromsarscoronavirus2lemonstransitioningasmokingcessationtrialtoavirtualplatform
AT asharerebecca makinglemonadefromsarscoronavirus2lemonstransitioningasmokingcessationtrialtoavirtualplatform
AT schlienznicolas makinglemonadefromsarscoronavirus2lemonstransitioningasmokingcessationtrialtoavirtualplatform
AT duerrcece makinglemonadefromsarscoronavirus2lemonstransitioningasmokingcessationtrialtoavirtualplatform
AT hawklarryw makinglemonadefromsarscoronavirus2lemonstransitioningasmokingcessationtrialtoavirtualplatform

Ejemplares similares